Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.74 |
| ▸ | NOD1 | Q9Y239 | 11/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26076118 | 0.94 | GLP1R (0.77) | GLP1RNOD1 | |
| SCHEMBL15357538 | 0.94 | GLP1R (0.67) | GLP1RNOD1 | |
| SCHEMBL16638273 | 0.94 | GLP1R (0.67) | GLP1RNOD1 | |
| SCHEMBL24891117 | 0.94 | GLP1R (0.67) | GLP1RNOD1 | |
| SCHEMBL16947959 | 0.94 | GLP1R (0.67) | GLP1RNOD1 | |
| SCHEMBL24890886 | 0.94 | GLP1R (0.67) | GLP1RNOD1 | |
| SCHEMBL16638274 | 0.94 | GLP1R (0.67) | GLP1RNOD1 | |
| SCHEMBL16947828 | 0.94 | GLP1R (0.67) | GLP1RNOD1 | |
| SCHEMBL21243001 | 0.93 | GLP1R (0.66) | GLP1RNOD1 | |
| SCHEMBL8213542 | 0.91 | GLP1R (0.83) | GLP1RNOD1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070203058-A1 | Novel Glp-1 Derivatives | NOVO NORDISK A/S (DK) | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203058-A1 | Novel Glp-1 Derivatives | GLP1R, GIPR, NPY4R | GLP1R 1/4885NOD1 410/4885EPHX2 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.